PROMETIC’S PBI-4050 TO TARGET IDIOPATHIC PULMONARY FIBROSIS (“IPF”) AS ONE OF ITS ORPHAN INDICATIONS

October 15, 2014
Posted by: Prometic Prometic
Posted In: Press Releases, Press Releases 2014
X